Our data show that APRIL‐based CAR T cells can effectively migrate to tumor spots, form clusters, and eliminate both BCMA positive and negative tumor cells, while anti‐BCAR T cells failed to do so toward BCMA negative tumor cells. Here, TNFRSF17 is linked to neoplasm.